Global Digital Breast Tomosynthesis DBT System Market Size By Type (2D Digital Mammography Technology, 3D Digital Mammography Technology), By Application (Hospitals, Diagnostic Centers), By Region, An...

The Global Digital Breast Tomosynthesis (DBT) System Market was valued at USD 2.1 billion in 2023 and is projected to surpass USD 4.9 billion by 2031, growing at a CAGR of 10.9% during the forecast period of 2023-2031. The increasing prevalence of breast cancer, rising awareness regarding early diagnosis, and growing technological advancements in breast imaging are driving the growth of the DBT system market globally. DBT systems provide superior imaging accuracy, reduce false positives, and enable early detection of breast cancer compared to conventional mammography, positioning them as a preferred diagnostic tool in hospitals and diagnostic centers.

Drivers

Rising Prevalence of Breast Cancer

Breast cancer remains one of the leading causes of cancer-related deaths among women globally. Early detection plays a crucial role in reducing mortality rates, leading to a surge in the adoption of advanced DBT systems.

Technological Advancements in Breast Imaging

Continuous innovations in imaging technology, such as 3D mammography, integration of artificial intelligence (AI), and development of low-dose radiation systems, are enhancing the accuracy and efficiency of DBT systems, accelerating their market adoption.

Growing Awareness of Early Diagnosis

Increasing government initiatives, awareness campaigns, and breast cancer screening programs are encouraging early-stage detection, boosting the demand for DBT systems across developed and developing regions.

Restraints

High Cost of DBT Systems

The high initial cost associated with DBT systems, coupled with maintenance expenses, can act as a barrier to widespread adoption, particularly in developing regions with limited healthcare budgets.

Radiation Exposure Concerns

Despite technological advancements, concerns regarding radiation exposure during repeated breast imaging procedures may limit the use of DBT systems among certain patient groups.

Opportunity

Growing Adoption in Emerging Markets

Emerging economies in Asia-Pacific and Latin America present lucrative opportunities for market expansion due to improving healthcare infrastructure, rising disposable incomes, and increasing awareness about breast cancer screening.

Integration of Artificial Intelligence (AI)

The integration of AI with DBT systems offers enhanced diagnostic accuracy, reduced reading times, and better clinical decision-making, creating new opportunities for market players to introduce advanced solutions.

Market by System Type Insights

Based on system type, the 3D Mammography segment accounted for the largest market share in 2023. 3D mammography provides high-resolution imaging, enabling the detection of small tumors and lesions that may be missed by traditional 2D mammography. The segment is expected to witness continued growth due to increasing demand for accurate breast cancer screening solutions.

Market by End-use Insights

In terms of end-use, the Hospitals segment emerged as the largest revenue contributor in 2023, holding over 45% of the market share. Hospitals prefer advanced DBT systems for early cancer detection and treatment planning. Diagnostic Centers are also expected to witness substantial growth during the forecast period due to the increasing establishment of specialized breast imaging facilities.

Market by Regional Insights

Geographically, North America dominated the global DBT system market in 2023, attributed to the high prevalence of breast cancer, favorable reimbursement policies, and advanced healthcare infrastructure. Asia-Pacific is projected to register the highest growth rate during the forecast period, driven by rising healthcare awareness, increasing healthcare expenditure, and growing breast cancer screening programs in countries like China, India, and Japan.

Competitive Scenario

Key players operating in the global digital breast tomosynthesis system market include:

Hologic, Inc.

Siemens Healthineers

GE Healthcare

Fujifilm Holdings Corporation

Planmed Oy

IMS Giotto S.p.A.

Konica Minolta, Inc.

Carestream Health

Canon Medical Systems Corporation

Metaltronica S.p.A.

These companies focus on product innovation, strategic partnerships, mergers & acquisitions, and regional expansion to strengthen their market position.

Scope of Work – Global Digital Breast Tomosynthesis (DBT) System Market

Report Metric Details

Market Size (2023) USD 2.1 Billion

Projected Market Size (2031) USD 4.9 Billion

CAGR (2023-2031) 10.9%

Key Segments by System Type 3D Mammography, 2D/3D Combination Systems

Key Segments by End-use Hospitals, Diagnostic Centers, Specialty Clinics

Leading Region North America

Key Players Hologic, Siemens Healthineers, GE Healthcare, Fujifilm, Canon Medical

Market Drivers Rising Breast Cancer Prevalence, Technological Advancements, Early Diagnosis Awareness

Market Opportunities AI Integration, Emerging Market Expansion

Key Market Developments

In 2023, Hologic, Inc. launched a next-generation DBT system with enhanced AI algorithms designed to improve diagnostic accuracy and workflow efficiency.

Siemens Healthineers announced a partnership in 2024 with a leading healthcare provider in Asia-Pacific to deploy DBT systems in breast cancer screening centers.

Fujifilm Holdings Corporation introduced an ultra-low-dose 3D mammography system in 2023 to address concerns regarding radiation exposure.

FAQs

1) What is the current market size of the Global Digital Breast Tomosynthesis (DBT) System Market?

The Global Digital Breast Tomosynthesis System Market was valued at USD 2.1 billion in 2023.

2) What is the major growth driver of the Global Digital Breast Tomosynthesis (DBT) System Market?

The major growth driver is the rising prevalence of breast cancer and increasing demand for early-stage diagnosis using advanced imaging systems.

3) Which is the largest region during the forecast period in the Global Digital Breast Tomosynthesis (DBT) System Market?

North America accounted for the largest market share in 2023.

4) Which segment accounted for the largest market share in the Global Digital Breast Tomosynthesis (DBT) System Market?

The 3D Mammography segment accounted for the largest market share in 2023.

5) Who are the key market players in the Global Digital Breast Tomosynthesis (DBT) System Market?

Key players include Hologic, Inc., Siemens Healthineers, GE Healthcare, Fujifilm Holdings Corporation, Planmed Oy, and Canon Medical Systems Corporation.